https://www.selleckchem.com/pr....oducts/anlotinib-al3
In both diseases, CRP was significantly increased on admission compared to both resolution and stable disease. Finally, TNF-a could distinguish between asthma and COPD stable phase. Leptin and CRP levels may be useful biomarkers in monitoring COPD and asthma response to treatment during an exacerbation episode. Hypoadiponectinemia was detected in asthma and COPD during all stages of the diseases. TNF-a could distinguish between asthma and COPD stable phase. Leptin and CRP levels may be useful biomarkers in monitoring COPD and a
Curtir
Comentario
Compartilhar
